Overview

A Clinical Trial to Investigate Safety/Tolerability and Pharmacokinetics of DA-1229_01(Evogliptin/Metformin XR 2.5/500 mg x 2 Tablets) Compared to Co-administration of Evogliptin 5 mg and Metformin XR 1000 mg in Healthy Male Volunteers

Status:
Completed

Trial end date:
2015-06-01

Target enrollment:

Participant gender:

Summary

This Phase I clinical study is to evaluate the safety/tolerability and pharmacokinetics of DA-1229_01(Evogliptin/Metformin XR 2.5/500 mg x 2 tablets).

Phase:

Phase 1

Details

Lead Sponsor:

Dong-A ST Co., Ltd.

Treatments:

Metformin